Biotech Values

[DewDiligence]

Osagie Imasogie buys $200K of GENR in open market:

GENR’s independent director Imasogie filed three SEC Form-4’s today (two of which appear to be duplicates). These filings show a purchase of 25,000 shares beginning on May 11 at an average price of $3.96, and a purchase of 26,150 shares beginning on May 14 at an average price of $3.73. Thus, Imasogie now owns 51,150 shares at an average price a little under $4/share. He also holds 20K options exercisable at $3.50 which were granted when Imasogie officially began his tenure on GENR’s B.O.D. in January.

(For GENR’s insider holdings excluding these purchases by Imasogie, please see: #msg-3069875.)

--
Recently, OXGN’s CEO and CSO bought $14-15K each of shares on the open market, which I criticized as token, cosmetic purchases. As a shareholder, Imasogie’s purchases of approximately $200K are much more to my liking!